… of ECMO-rescued patients with severe COVID-19 ARDS in our … Failure of prolonged
non-invasive oxygenation strategies … COVID-19 treatments might partially explain this outcome. …

… , an evolution that requires continued surveillance of ECMO outcomes in COVID-19. …
respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19): pooled …

… ECMO for COVID-19-related ARDS has increased as the pandemic has progressed. The
reasons for this are likely multifactorial; however, as outcomes for these patients evolve, the …

… with COVID-19 who develop severe acute respiratory distress syndrome (ARDS) can have
symptoms that rapidly evolve … and outcomes of patients with respiratory failure and COVID-19 …

… may have inferior outcomes [35,36,37,38]. … severe ARDS secondary to COVID-19; however,
as global experience with ECMO for patients with COVID-19 grows and as outcomes evolve, …

… supports benefit. Here we compare our institution's ECMO outcomes across multiple waves
of the COVID-19 … unique approach to ECMO for COVID-19 ARDS. Since our previous …

… -COVID-19 acute respiratory distress syndrome (ARDS). However, less favourable outcomes
… were to report the evolving characteristics, management, and outcomes of these patients …

… and varied outcomes in patients who developed severe acute … As the pandemic has
evolved, lower mortality attributable to … extracorporeal membrane oxygenation providers. …

… The role of ECMO in severe ARDS because of COVID-19 is less well established and has
evolved … that outcomes with ECMO in COVID-19-related ARDS were similar to those for non-…

… ECMO is rapidly evolving, 6 various adverse effects have been … effects in patients undergoing
VV ECMO due COVID-19 … the treatment of COVID-19-associated ARDS given that mortality …